A new study suggests that HIV infected patients should start antiretroviral treatment earlier. Here’s the editor’s note accompanying the article in today’s online version of the Lancet: “When to start antiretroviral treatment has been a problem for physicians dealing with patients with HIV infection. Most commonly the decision is based on CD4 counts, […]
The meeting in Beijing last week of health ministers from high-burden MDR and XDR TB countries has produced some significant results, at least on paper. Perhaps most notably, participants “committed to help mobilize $2 billion needed over the next two years to adequately finance the TB and M/XDR-TB response from both domestic and international resources […]
HIV
With a matter-of-fact and unanimous approval of the PEPFAR Extension Act of 2018, a five-year renewal of the U.S. flagship program to combat HIV globally, the […]
Tuberculosis
THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
The report on outcomes of measles elimination efforts released last week by the World Health Organization and the U.S. Centers for Disease Control and Prevention shows, […]